Tara Bancroft
Stock Analyst at TD Cowen
(2.79)
# 1,986
Out of 5,056 analysts
10
Total ratings
62.5%
Success rate
22.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $11.76 | +70.07% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $53.50 | +49.53% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $31.21 | +60.21% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $84.39 | -22.98% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.11 | +800.90% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $95.80 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $6.47 | - | 1 | Aug 31, 2022 |
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $11.76
Upside: +70.07%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $53.50
Upside: +49.53%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $31.21
Upside: +60.21%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $84.39
Upside: -22.98%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.11
Upside: +800.90%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $95.80
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $6.47
Upside: -